Literature DB >> 22628235

A spectrophotometric method to precisely determine endpoint titers in complement fixation assays.

Ryan J Welch1, Stephen D Merrigan, Julio C Delgado.   

Abstract

Since the early 20th century, complement fixation (CF) testing has been used to quantify the humoral response to various pathogens. The qualification of a positive result is based on a subjective determination of 30% lysis of sheep red blood cells, which can lead to variability in the analysis. A spectrophotometric reading of a standard with a known 30% lysis was used to standardize the currently used CF method and tested with controls and patient sera for various fungal assays. By utilizing this method a precise and non-subjective determination of endpoint titers was achieved.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22628235      PMCID: PMC6807393          DOI: 10.1002/jcla.21509

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  5 in total

Review 1.  Laboratory methods for the diagnosis and confirmation of systemic mycoses.

Authors:  L Kaufman
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

2.  Standardized diagnostic complement fixation method and adaptation to micro test.

Authors: 
Journal:  Public Health Rep       Date:  1965-07       Impact factor: 2.792

3.  The 100th anniversary of Wassermann-Neisser-Bruck reaction.

Authors:  Rafal Bialynicki-Birula
Journal:  Clin Dermatol       Date:  2008 Jan-Feb       Impact factor: 3.541

4.  Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies.

Authors:  J L Dangl; T G Wensel; S L Morrison; L Stryer; L A Herzenberg; V T Oi
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

5.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

Authors:  M Brüggemann; G T Williams; C I Bindon; M R Clark; M R Walker; R Jefferis; H Waldmann; M S Neuberger
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.